COTI-2 reactivates mutant p53 and inhibits growth of triple-negative breast cancer cells

被引：0
|
作者：
Naoise C. Synnott
David O’Connell
John Crown
Michael J. Duffy
机构：
[1] University College Dublin,UCD School of Medicine, Conway Institute of Biomolecular and Biomedical Research
[2] University College Dublin,UCD School of Biomolecular & Biomedical Science
[3] St. Vincent’s University Hospital,Department of Medical Oncology
[4] St. Vincent’s University Hospital,UCD Clinical Research Centre
来源：
Breast Cancer Research and Treatment | 2020年 / 179卷
关键词：
p53; TP53; COTI-2; Triple-negative breast cancer; Treatment; APR-246;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：47 / 56
页数：9
相关论文
共 50 条
  • [1] COTI-2 reactivates mutant p53 and inhibits growth of triple-negative breast cancer cells
    Synnott, Naoise C.
    O'Connell, David
    Crown, John
    Duffy, Michael J.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 179 (01) : 47 - 56
  • [2] Targeting mutant p53 with COTI-2: A new approach for the treatment of patients with triple-negative breast cancer?
    Synnott, Naoise C.
    O'Connell, David J.
    Crown, John
    Duffy, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] Degradation of MYC by the mutant p53 reactivator drug, COTI-2 in breast cancer cells
    Minhong Tang
    John Crown
    Michael J Duffy
    Investigational New Drugs, 2023, 41 : 541 - 550
  • [4] Degradation of MYC by the mutant p53 reactivator drug, COTI-2 in breast cancer cells
    Tang, Minhong
    Crown, John
    Duffy, Michael J.
    INVESTIGATIONAL NEW DRUGS, 2023, 41 (4) : 541 - 550
  • [5] Generation of a transcriptome of oncogenic mutant p53 in triple-negative breast cancer
    Steele, Rebecca E.
    McDade, Simon S.
    Mullan, Paul B.
    CANCER RESEARCH, 2017, 77
  • [6] Mutant p53 as a Therapeutic Target for the Treatment of Triple-Negative Breast Cancer
    Synnott, N.
    Crown, J.
    Duffy, M. J.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E41 - E41
  • [7] Mutant p53: A therapeutic target for the treatment of triple-negative breast cancer?
    Synnott, Naoise C.
    Pierce, Aisling
    Mullooly, Maeve
    Caiazza, Francesco
    McGowan, Patricia M.
    O'Donovan, Norma
    Crown, John
    Duffy, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] Role of Reactivating Mutant p53 Protein in Suppressing Growth and Metastasis of Triple-Negative Breast Cancer
    Berke, Taylor P.
    Slight, Simon H.
    Hyder, Salman M.
    ONCOTARGETS AND THERAPY, 2022, 15 : 23 - 30
  • [9] Mutant p53: a novel target for the treatment of patients with triple-negative breast cancer?
    Synnott, N. C.
    Murray, A.
    McGowan, P. M.
    Kiely, M.
    Kiely, P. A.
    O'Donovan, N.
    O'Connor, D. P.
    Gallagher, W. M.
    Crown, J.
    Duffy, M. J.
    INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (01) : 234 - 246
  • [10] ERβ decreases the invasiveness of triple-negative breast cancer cells by regulating mutant p53 oncogenic function
    Bado, Igor
    Nikolos, Fotis
    Rajapaksa, Gayani
    Gustafsson, Jan-Ake
    Thomas, Christoforos
    ONCOTARGET, 2016, 7 (12) : 13599 - 13611
12345